Tamer Önder
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Tamer Önder is a professor at Koç University, specializing in molecular biology and genetics.[1] Born on November 12, 1980, in Istanbul, Turkey, his work primarily focuses on stem cell biology and cancer.[2]
Early life and education
[edit]This section of a biography of a living person does not include any references or sources. (November 2023) |
Önder graduated from American Robert College of Istanbul in 1998. He completed his undergraduate degree in Molecular Biology and Genetics at Cornell University.
From 2002 to 2008, Önder pursued his PhD at the Massachusetts Institute of Technology (MIT), under the guidance of Prof. Robert Weinberg. His thesis work was centered on cancer metastasis and cancer stem cells.
After completing his PhD, Önder joined Harvard Medical School for his postdoctoral studies under Prof. George Daley, focusing on stem cells, specifically somatic cell reprogramming and induced pluripotent stem cells.
Career
[edit]In June 2012, Önder was appointed as a faculty member at Koç University School of Medicine. His research interests include the molecular mechanisms of stem cell formation and the generation of patient-specific stem cells.[3]
Publications and citations
[edit]Önder has authored several articles and holds patents in the field of molecular biology. His work has been published in journals such as PNAS, Cell, and Nature. His research has received over 5,000 citations.[4]
He is also a full member of The Science Academy Society of Turkey.[1]
References
[edit]- ^ a b "People – Onder Lab". Retrieved 2023-11-11.
- ^ "https://twitter.com/Tamer_Onder". X (formerly Twitter). Retrieved 2023-11-11.
{{cite web}}
: External link in
(help)|title=
- ^ "Tamer Önder - Koç Üniversitesi". 2020-03-19. Retrieved 2023-11-11.
- ^ "Tamer T. Onder". scholar.google.com. Retrieved 2023-11-11.
This article needs additional or more specific categories. (November 2023) |